West Virginia University Logo

May 7, 2014


SAMHSA Prescription Drug Abuse Weekly Update
Issue 70  |  May 7, 2014
The Prevention of Prescription Drug Abuse in the Workplace (PAW) TA Center addresses prescription drug abuse—a growing public health problem with increasing burdens on workers, workplaces, and our economy. To subscribe colleagues, family members, or friends to this listserv sponsored by the Substance Abuse and Mental Health Services Administration (SAMHSA), please click here or send their e-mail addresses to paw@dsgonline.com.
Table of Content Featured Article Journal Articles and Reports Professional Education & Editorial News Other State and Local News Other Resources Videos Webcast Grant Announcement Grant Awarded Take-Back Events Save the Date Upcoming Conferences and Workshops


Nora D. Volkow, Thomas R. Frieden, Pamela S. Hyde, and Stephen S. Cha. 2014. Perspective: "Medication-Assisted Therapies—Tackling the Opioid-Overdose Epidemic." New England Journal of Medicine, doi:10.1056/NEJMp1402780

The heads of the National Institute on Drug Abuse, the Centers for Disease Control and Prevention, the Substance Abuse and Mental Health Services Administration, and the medical director of the Centers for Medicare & Medicaid Services discuss barriers to using medicated-assisted therapies or treating patients with opioid addiction and the government's efforts to expand their use. The three underutilized medication-assisted therapies are methadone, buprenorphine, and naltrexone. Of 2.5 million Americans age 12 and older who abused or were dependent on opioids in 2012, fewer than 1.0 million received these therapies. When prescribed and monitored properly, they are proven to help patients recover. Nevertheless, they have been adopted in fewer than half of private-sector treatment programs, and even in programs that offer them only 34.4 percent of patients receive them. The American Society of Addiction Medicine reports that usage barriers include utilization-management techniques such as limits on dosages prescribed, annual or lifetime medication limits, initial authorization and reauthorization requirements, minimal counseling coverage, and "fail first" criteria requiring that other therapies be attempted first. The article closes by describing federal efforts to increase the availability and use of medication-assisted therapies.

Read more:

Tennessee Passes Law Criminalizing Moms Who Used Drugs While Pregnant
April 30, 2014

Tennessee became the first state in the country to sign a bill into law that would allow charges to be brought against a new mother if her infant's "addiction or harm is a result of her illegal use of a narcotic drug taken while pregnant." National medical organizations, local advocates, and doctors worry that the infant mortality rate will get only worse if women opt to turn away health care out of fear of being arrested for abusing drugs. The legislation includes criminal penalties but allows mothers to escape prosecution if they complete drug treatment. The measure has a sunset provision, with the criminal penalty in effect only until 2016 when lawmakers can assess its impact.

Read more:

Journal Articles and Reports

Natalie Colaneri, Majnu John, and Andrew Adesman. 2014. "Prevalence and Student Perceptions of Prescription Stimulant Misuse at an Ivy League College." Presentation at the Pediatric Academic Societies Annual Meeting, Vancouver, British Columbia, May 3.

This study analyzed prevalence and perceptions of stimulant medication misuse for academic purposes based on an anonymous online survey emailed to all sophomores, juniors, and seniors at an Ivy League college in December 2012. Among 616 responding non–ADHD college students, 18 percent had used at least one stimulant medication to study in college and 9 percent had used two or more formulations. Sixteen percent of seniors, 24 percent of juniors, and 13 percent of sophomores admitted to stimulant medication misuse for academic purposes. Stimulant medication misuse for academic purposes was more common among college students affiliated with a varsity team and a Greek house compared with college students affiliated with one or neither (28 percent versus 16 percent, p=0.0085). No difference in stimulant medication misuse for academic purposes was noted between college students who did and did not receive financial aid (19 percent versus 17 percent). As for frequency of stimulant medication misuse for academic purposes, 26 percent of college students who previously misused stimulant medication did so four to eight times and an additional 24 percent did so more than eight times. Among respondents , 41 percent believed stimulant medication misuse for academic purposes was cheating, 33 percent thought it was not cheating, and 25 percent were unsure.

Read more:

Katherine M. Houle and Susan J. Simonian. 2014. "Adolescent Swimmers: Breathing Complaints and Prescription Asthma Medication Use and Misuse." Children's Health Care 43(2):96–109, doi: 10.1080/02739615.2013.867787

This study analyzed surveys completed by 103 competitive adolescent swimmers from 17 club-level South Carolina swim teams competing in the USA Swimming Association state championships. Forty-five percent had experienced exercise-induced asthma. While some had prescriptions for asthma medications, others tended to borrow or steal these medications when in need. In univariate tables, misuse was more common among swimmers who were older, swam more miles per practice, and practiced more days. Older swimmers also were marginally more likely to take a greater dose of medication than was prescribed (p=0.079).

Read more:

Guohua Li, Joanne E. Brady, Barbara H. Lang, James Giglio, Hannah Wunsch, and Charles DiMaggio. 2014. "Prescription Drug Monitoring and Drug Overdose Mortality." Injury Epidemiology 1:9. doi:10.1186/2197–1714–1–9.

This study assessed the correlation between prescription drug overdose mortality and having a state prescription drug monitoring program (PDMP) in place. Researchers analyzed quarterly overdose mortality data by state for 1999 through 2008. PDMP presence was associated with an 11 percent increase in drug overdose mortality (95 percent CI=2 percent to 21 percent). This could mean simply that PDMPs are implemented in places with growing overdose problems and cannot completely turn the tide. The analysis could not fully control for PDMP usage level. Of the 31 implemented PDMPs included, the 11 that explicitly exempted practitioners from the obligation to access the PDMP had greater drug overdose mortality than other PDMPs.

Read more:

A. Sanders, J. Stogner, J. Seibert, and B.L. Miller. 2014. "Misperceptions of Peer Pill-Popping: The Prevalence, Correlates, and Effects of Inaccurate Assumptions About Peer Pharmaceutical Misuse." Substance Use and Misuse 49(7):813–23, doi: 10.3109/10826084.2014.880485.

This study surveyed 2,349 college students at a southeastern U.S. university about peer pharmaceutical misuse. In the past month, 9.6 percent had misused prescription stimulants and 4.9 percent had misused prescription pain relievers. More than half of students accurately estimated peer use rates in each of the four pharmaceutical groups: stimulants, pain relievers, sedatives, and anabolic steroids. Two thirds of those who misperceived peer misuse overestimated it. Overestimates of peer use were substantially greater for heavy drinking and illicit drug use than for prescription misuse.

Read more:

Ty S. Schepis. 2014. "Age Cohort Differences in the Nonmedical Use of Prescription Zolpidem: Findings From a Nationally Representative Sample." Addictive Behaviors, doi: 10.1016/j.addbeh.2014.04.018.

This study used 2009–11 National Survey on Drug Use and Health data to analyze correlates of nonmedical use of zolpidem across the lifespan. Especially at younger ages, most substance use and mental health variables correlated with nonmedical use.

Read more:

Genevieve Verdi, Lisa L. Weyandt, and Brynheld Martinez Zavras. 2014. "Nonmedical Prescription Stimulant Use in Graduate Students: Relationship With Academic Self-Efficacy and Psychological Variables." Journal of Attention Disorders, doi: 10.1177/1087054714529816.

A survey of 807 graduate students from universities located in five U.S. regions revealed the past-year rate of self-reported nonmedical use of prescription drugs was 5.9 percent, with lifetime prevalence of 17.5 percent. Nonmedical use of prescription stimulants was significantly correlated with anxiety, stress, internal restlessness, and perceived safety of the medications.

Read more:

Roger D. Weiss, Margaret L. Griffin, Jennifer Sharpe Potter, Dorian R. Dodd, Jessica A. Dreifuss, Hilary S. Connery, and Kathleen M. Carroll. 2014. "Who Benefits From Additional Drug Counseling Among Prescription Opioid Dependent Patients Receiving Buprenorphine–Naloxone and Standard Medical Management?" Drug and Alcohol Dependence, doi:10.1016/j.drugalcdep.2014.04.005.

In the multisite Prescription Opioid Addiction Treatment Study, participants randomly assigned to receive individual drug counseling in addition to buprenorphine, naloxone, and medical management did not have superior opioid use outcomes. Heroin users who received drug counseling were more likely to be abstinent or nearly abstinent from opioids than ones who received medical management alone (odds ratio [OR]=3.7, 95 percent CI=1.1–11.8, p=0.03). The association between severity and outcome did not vary by treatment approach or Addiction Severity Index score.

Read more:

Elizabeth A. Wright, Jeffrey N. Katz, Stanley Abrams, Daniel H. Solomon, and Elena Losina. 2014. "Trends in Prescription of Opioids From 2003 to 2009 in Persons With Knee Osteoarthritis." Arthritis Care & Research, doi:10.1002/acr.22360.

Researchers studied people with knee osteoarthritis in the 2003, 2006, and 2009 waves of the Medicare Beneficiary Survey. Mean age and sex were similar across years (77 years, 69 percent females). Patients prescribed opioids during the year rose from 31 percent in 2003 to 39 percent in 2006 and 40 percent in 2009. Multivariate logistic regression indicated opioid use was more likely for females (OR=1.5, 95 percent CI 1.2–2.0), as were greater functional limitations (OR=2.1, 95 percent CI 1.6–2.7), poor self-reported health status (OR=1.6, 95 percent CI 1.2–2.0), chronic obstructive pulmonary disease (OR=1.4, 95 percent CI 1.0–1.8), and musculoskeletal disease besides osteoarthritis (OR=1.9, 95 percent CI 1.2–2.8).

Read more:

Li–Tzy Wu and Dan G. Blazer. 2014. "Substance Use Disorders and Psychiatric Comorbidity in Mid and Later Life: A Review." International Journal of Epidemiology 43(2):304–17, doi: 10.1093/ije/dyt173.

The authors systematically reviewed studies published between 2005 and 2013 on substance use disorders among community noninstitutionalized adults age 50 and older. They found that 1 percent to 2 percent misused prescription drugs in the past year, with treatment admissions rising. Older drug users in methadone maintenance treatment exhibited multiple psychiatric or medical conditions.

Read more:

C.S. Zin, L.–C. Chen, and R.D. Knaggs. 2014. "Changes in Trends and Pattern of Strong Opioid Prescribing in Primary Care." European Journal of Pain, doi:10.1002/j.1532–2149.2014.496.x

This study evaluated primary-care prescribing trends in the United Kingdom from 2000 through 2010 for four commonly prescribed strong opioids—buprenorphine, fentanyl, morphine, and oxycodone—and usage patterns in noncancer and cancer patients. The United Kingdom Clinical Practice Research Datalink showed 178,692 adult patients (83.9 percent noncancer) received 2,672,022 prescriptions (87.8 percent for noncancer) over 10 years. Mean patient age was 67 with 60 percent female. The mean defined daily dose/1,000 inhabitants/day was higher in the noncancer group than in the cancer group for all four opioids. Most patients were prescribed low opioid doses (oral morphine equivalent ≤50 mg/day) in both noncancer (50.3 percent) and cancer (39.9 percent) groups.

Read more:

Professional Education & Editorial

Ted Goodman. 2014. "The Need for Prescription Drug Buy-Back Programs," Tennessee Journal of Law and Policy 6(1), Article 5.

This essay proposes that governments consider providing financial incentives for patients to "turn in" unneeded medications to the proper authorities. Such a program could be funded largely—if not entirely—by private sources, government grants, and savings in healthcare and the criminal justice system.

Read more:

Joy Jacobson. 2014. "Heroin: Life, Death, and Politics." American Journal of Nursing 114(5):22–23, doi: 10.1097/01.NAJ.0000446774.91899.b5.

A heroin epidemic spurs new laws, as nurses work to prevent deaths. They include the passage of Good Samaritan and/or naloxone access bills throughout the country.

Read more:

Yngvild Olsen and Joshua M. Sharfstein. 2014. "Perspective: 'Chronic Pain, Addiction, and Zohydro.'" New England Journal of Medicine, doi:10.1056/NEJMp1404181

The authors argue that a more comprehensive and coherent strategy is urgently needed to address chronic pain and addiction. Zohydro will not resolve the tension that exists between the two. The authors suggest that approaches to managing clinical situations effectively should be a focal point of research funding, a subject for education in medical and dental schools, and a topic for training in accredited residency programs. They also believe that the federal government can do more to promote concurrent treatment of chronic pain and addiction among patients who are at greatest risk for both disorders. The authors also suggest that the Food and Drug Administration consider creating a pathway for development and review of new products and indications for simultaneous treatment of chronic pain and opioid-use disorder. It should require that prescription opioids meet basic deterrent standards and should facilitate gradual reformulation of existing products to meet those standards.

Read more:

The Way Forward on Opioid Abuse: A Call to Action for Science-Based, Comprehensive Strategies
FDA Voice
April 29, 2014

Food and Drug Administration (FDA) Commissioner Margaret Hamburg writes about strategies to prevent prescription opioid abuse—FDA's biggest priority. "The recent attention paid by state policymakers around the serious public health problem of misuse, abuse, addiction, and overdose of prescription opioid painkillers is commendable," she notes. "These efforts reflect the strong desire on the part of states where communities have been devastated by opioid addiction and overdose to prevent further tragic loss of life. However, it is important that such efforts comprehensively address the real root causes of the problem, are grounded in science, and will make a real and lasting difference."

Read more:


Prescription Drug Monitoring, Insurance Coverage for Addiction Bills Clear Senate Hurdle
Rhode Island Public Radio
April 30, 2014

A Rhode Island senate committee moved forward two bills aimed at curbing prescription drug and heroin abuse. One would require health insurers to cover medications that treat prescription pain reliever and heroin abuse and require healt care facilities to include a link to substance abuse treatment in patient discharge plans that include an opioid prescription. The second would require doctors who prescribe controlled substances to use the state's prescription drug monitoring program and would allow doctors to designate an employee to use the system.

Read more:

Campaign Targets Growing Misuse of Prescription Drugs
Navy Times
April 29, 2014

The U.S. Navy launched "Prescription for Discharge," a campaign aimed to ensure that sailors report prescriptions, correctly take them, and dispose of unneeded extras. In the first seven months of this fiscal year, 524 sailors tested positive for illegal prescription drug usage. Sailors ages 18 to 25 accounted for 71 percent of positive drug tests. Sailor focus groups found that many sailors thought it was "OK" to take medication that had been prescribed to a family member.

Read more:

Medication Misuse: A Growing Problem
U.S. Air Force
April 30, 2014

This article discusses misuse of prescription drugs among service members. It reports that an estimated 2.4 million Americans used prescription drugs nonmedically for the first time in 2013. That equates to more than 6,550 new cases of improper use each day. The most commonly misused drugs in the Air Force are opioids, especially Vicodin and Oxycontin, with misuse of stimulants such as Ritalin and Adderall also rising. The article defines misuse and stresses the importance of disposing of leftover medications. It warns service members who self-medicate with their prior prescription. If these drugs are found in their system during a drug test, they may be subject to nonjudicial punishment. Punishments can include loss of pay or rank, base restriction, or a reprimand.

Read more:

Prescription Drug Business Is Big and Getting Bigger
Wall Street Journal
April 28, 2014

IMS Health, a health research and analytics firm, estimates global spending on medicines will reach $1.2 trillion in 2017, up from $731 billion in 2007. According to the latest Centers for Disease Control and Prevention data, the number of prescription drugs the average American uses will also be going up, as the median age in the United States moves higher. The increase is highest among people over 65 but is expected to grow for all age groups. Editor's Note: Prescription abuse historically has grown in proportion to prescription volume.

Read more:

Illegal Online Sellers Most Frequent Distributors of Counterfeit Drugs
National Association of Boards of Pharmacy
April 25, 2014

The National Association of Boards of Pharmacy (NABP) issued a report showing illegal online drug sellers are the most frequent conduits of counterfeit drugs and pose a continued threat to global public health. As detailed in the Internet Drug Outlet Identification Program Progress Report for State and Federal Regulators (April 2014), most rogue Internet drug outlets sell prescription drug products directly to consumers without requiring a valid prescription. Many are also distributing controlled substances, putting patients at high risk for abuse and addiction. To protect consumers, NABP and a global coalition of stakeholders are moving plans forward to launch the pharmacy generic Top-Level Domain (gTLD). The association and its member state boards of pharmacy continue to work with federal regulators and other public and private entities to educate the public about the dangers of buying medications from rogue Internet drug sellers.

Read more:

Zohydro: Why This New Painkiller Could Spark Another Addiction Epidemic
Fox News
April 28, 2014

Many health experts want Zohydro off the market. The extended-release drug, which contains hydrocodone, is designed to slowly release pain-relieving medication into the body over a 12-hour period. Zohydro is available in doses as high as 50 milligrams—five times the amount found in similar immediate-release hydrocodone pills.

Read more:

Q&A With Addiction Medicine Expert: The Impact of Zohydro
Partnership at Drugfree.org
April 30, 2014

The Food and Drug Administration's decision to approve Zohydro ER has stirred opposition from many addiction medicine experts, public health officials, and legislators. Join Together spoke with Dr. Richard Blondell, Vice Chair for Addiction Medicine in the State University of New York at Buffalo Department of Family Medicine, about the issue.

Read more:

States Challenge Food and Drug Administration Over Painkiller Zohydro
Milford Daily News
April 29, 2014

Notwithstanding a court order, Massachusetts and other states plan to restrict use of Zohydro, setting up a showdown with the federal government over who gets to decide the best way to protect public health. Although there haven't been specific cases of Zohydro abuse in Massachusetts, Gov. Deval Patrick fears the powerful new drug will make the prescription abuse crisis even worse.

Read more:

Opioid Safeguards Protect and Serve Patients
Washington Post
April 23, 2014

Roger Hawley, chief executive of Zogenix, responds to Charles Lane's April 17 Washington Post op–ed "Not the Prescription for Stopping Opioid Abuse." Making opioids tamper resistant has not slowed the growth of drug abuse in the United States, writes Hawley, whose company makes Zohydro. "The Drug Enforcement Administration has assigned Zohydro a U.S. production quota of less than 1 percent of all opioids," he said. "The medication is intended for use only by patients with severe daily chronic pain. It poses no real risk of increased misuse or abuse."

Read more:

American Insurance Association Endorses Brandeis University Report on PDMP and 3rd Party Payers in Workers' Compensation
April 23, 2014

The American Insurance Association endorsed Brandeis University's Prescription Drug Monitoring Program Center of Excellence report (see Weekly Update, Issue 69) recommending broad access to prescription drug monitoring data for third-party payers, to help payers fight against opioid abuse in the workers' compensation system.

Read more:

U.S. Department of Justice Audits Program
Justice.org (Brandeis University's student newspaper)
April 29, 2014

An audit of Brandeis' use of federal funding for its Prescription Drug Monitoring Program Center of Excellence claimed that $608,646 of four separate cooperative agreements totaling $3,826,950 and awarded from 2008 to 2011 were "unallowable" or "unsupported" expenses according to Office of Justice Programs spending guidelines. Brandeis disputed the findings in its official response to the Office of the Inspector General. The university agreed that $31,224 of the recommended total was unallowable or incorrectly charged and therefore should be remedied. This amount includes $23,923 that was charged to the wrong cooperative agreements and $7,301 for a subcontractor's staff members to attend a "pharmaceutical diversion summit" in Orlando, Fla., that was not in the original funding agreement. The audit concluded that the center met its goals.

Read more:

Nurses Aren't Immune to Prescription Drug Abuse
HealthLeaders Media
April 29, 2014

Nurses and other healthcare providers are not immune to prescription drug addiction. Along with recent news highlighting cases of prescription drug–addicted nurses, Kathleen Russell, an associate in the Nursing Regulations Division at the National Council of State Boards of Nursing, cites research from 1998 that showed although "substance use among nurses occurred at rates comparable to rates in [the] general population, [mis]use of prescription type drugs was higher among nurses."

Read more:

Canadian Association of Chiefs of Police Announce National Prescription Drug Drop-Off Day
Digital Journal
May 2, 2014

The Canadian Association of Chiefs of Police will hold a National Prescription Drug Drop-Off Day on Saturday, May 10. In addition, unused or unwanted prescriptions can be dropped off at local pharmacies throughout the year. Partnership for a Drug Free Canada will conduct its campaign, National Medicine Take-Back Campaign, beginning on May 31 until the end of 2014.

Read more:

Other State and Local News

North Caroline Report Tackles Prescription Drug Abuse
News and Observer
April 30, 2014

The Program Evaluation Division (PED), a legislature's watchdog agency, recommended that North Carolina require medical providers get routine training about prescription drug abuse and improve monitoring of controlled substance dispensing. The report also found North Carolina lacks statewide prescribing guidelines that apply to all doctors, dentists, and other medical providers who are subject to state licensure. The PED said the General Assembly should direct state health officials and occupational licensing boards like the North Carolina Medical Board and North Carolina Board of Nursing to develop guidelines for opioids and require all relevant boards to require licensees who prescribe controlled substances to receive at last one hour of continuing education on prescription drug abuse as a condition of license renewal. The state Department of Health and Human Services largely agreed with the recommendations, which also urged the Department to develop a strategic plan to combat prescription drug abuse.

Read more:

Editorial: Drugs Can Cause Recall Problems During Exams
April 29, 2014

Adderall is the drug of choice for many college students cramming for exams—one in five admits to using the medicine without a prescription. But although the drug can increase focus and help students stay awake, it's not without risk.

Read more:

How We Can Fight the Prescription Drug Abuse Epidemic
Atlanta Business Chronicle
April 22, 2014

Georgia Atty. Gen. Sam Olens discusses his efforts to protect the state from prescription drug abuse.

Read more:

Pitt County (N.C.) Deputies to Carry Overdose-Reversing Drug
April 30, 2014

The Pitt County Sheriff's Office will require its deputies to carry Narcan, the first requirement of its kind in North Carolina. The General Assembly passed "good Samaritan" legislation last year protecting bystanders who call for help or administer Narcan during an opiate overdose. Under the law, doctors can also prescribe Narcan to anyone at risk of opiate overdose and that person's family and friends.

Read more:

Western Massachusetts' Opioid Addiction Crisis Addressed in State Senate Session in Holyoke
Mass Live
April 28, 2014

During a special session on drug addiction and treatment options at Providence Behavioral Health Hospital, Northwestern District Attorney David Sullivan spoke about moving beyond what's known as the "spin-dry" approach to dealing with drug-dependent people held on bail. Spin-dry, Sullivan said, refers to the typical three- to five-day detoxification period provided for those without additional medical treatment or care. That approach has led to Franklin and Hampshire county jails becoming primary detoxification facilities while drug-dependent people are held on bail awaiting trial or a disposition.

Read more:

North Middlesex (Mass.) Cares Aims to Raise Prescription Drug Awareness
Community News, Nashoba Publishing
April 29, 2014

North Middlesex (NM) Cares aims to raise awareness about prescription drug abuse in Pepperell, Mass. On National Prescription Drug Take-Back Day, NM Cares held its first event, setting up a booth to promote prescription drug abuse awareness at the Pepperell Family Pharmacy. One of the group's next steps will be to partner with local schools to hold drug awareness events for students.

Read more:

Prescription Drug Abuse Epidemic Is Topic of Summit Thursday in Lower Paxton Township
Penn Live, Patriot–News
April 29, 2014

A summit initiated by Dauphin County, Pa., commissioners to draw attention to prescription abuse will be held May 1. In this first of two important meetings, a panel of national, state, and local experts will discuss what is being described as an epidemic.

Read more:

Kansas Woman Sentenced in Prescription Drug Case
Kansas First News
April 28, 2014

A woman has been placed on two years' probation for her role in a conspiracy to distribute prescription drugs at a northeast Kansas pain clinic. The United States Attorney's office says 30-year-old Sarah Harding–Huffine pleaded guilty in February to conspiracy to unlawfully distribute prescription drugs from Dr. Michael Schuster's Manhattan clinic.

Read more:

Action Needed to Curb Adderall Use Among College Students
Minnesota Daily
April 29, 2014

In fall 2013, 51,526 college students were enrolled at the University of Minnesota–Twin Cities. According to Boynton Health Service's 2013 College Student Health Survey, 5 percent of the students were diagnosed with attention deficit hyperactivity disorder. If they were all prescribed Adderall, as many as 2,576 students could be carrying Adderall that they might sell or share with friends.

Read more:

Other Resources

Speaker Presentations: 2014 National Rx Drug Abuse Summit
August 22–24, 2014
Atlanta, Georgia

Speaker presentations are now available for immediate download. The 2014 National Rx Drug Abuse Summit drew approximately 1,100 participants from 46 states, the District of Columbia, Canada, and New Zealand. Sessions at the Summit were organized into seven Educational Tracks tailored to provide stakeholders timely and relevant information for their particular field: Clinical, Education & Advocacy, Law Enforcement, Pharmacy, Prescription Drug Monitoring Programs, Third-Party Payer, or Treatment.

Read more:


Painkiller Addiction Can Be a Gateway to Heroin
CBS News
April 29, 2014

According to the National Institute on Drug Abuse, 1 in 15 people taking prescription pain medication for nonmedical reasons will try heroin within the next 10 years. Stephanie King's parents never thought she would become a heroin addict. But while studying at the University of Delaware, King was hospitalized for a severe stomach infection. The doctors sent her home with a prescription for Percocet. Soon the Percocet led to OxyContin. When law enforcement stopped the doctor from writing her prescriptions, King turned to heroin. [Duration: 1 minutes 35 seconds]


New Pain Pill Stronger Than Vicodin
April 28, 2014

The Commissioner of the Food and Drug Administration talks with Dr. Sanjay Gupta about the approval of Zohydro which raised concerns among some medical professionals and politicians. (Duration: 4:55)

http://www.cnn.com/video/?/video/health/2014/04/28/sgmd-gupta-hamburg-fda- zohydro.cnn&iref=allsearch&video_referrer=http%3A%2F%2Fwww.cnn.com%2 Fsearch%2F%3Fquery%3Dgupta%2Bfda%26primaryType%3Dmixed%26sort


The Evolving Drug-Free Workplace
Multijurisdictional Counterdrug Task Force
Available On-Demand

This hour-long Webcast discusses how some businesses are trying to keep their workers safe. It describes how testing programs work and how any company can implement them. It explains how the law protects companies even as attitudes change.


Grant Announcement

Prescription Drug Overdose: Boost for State Prevention
Centers for Disease Control and Prevention
Deadline: June 4, 2014

Grant Awarded

Garfield County (Okla.) Group Gets Grant to Combat Prescription Drug Abuse
April 28, 2014

The newly formed County Health Improvement Organization (CHIO) in Garfield County, Okla., has been awarded a $10,000 grant to fight prescription drug abuse. "The Garfield County CHIO builds a bridge between health care, health promotion, and disease prevention so that we can better serve our community," said Maggie Jackson, chair of Garfield County CHIO. "It has created greater access to information, resources, and partnerships."

Read more:

Take-Back Events

Iowans Set Records in Safe Prescription Drugs Disposal
Des Moines Register
May 1, 2014

Feds Set Record in Latest Drug Take-Back in West Virginia
April 30, 2014

600 Pounds of Unwanted Prescription Drugs Turned in to Hunterdon Police
April 29, 2014

Michigan State Police Collect Nearly 600 Pounds of Prescription Drugs
Leader Publications
April 29, 2014

Locals Dump More Than 250 Pounds of Prescription Medication at Drop-Off Event
MarionStar.com (Ohio)
April 29, 2014

Milwaukee, Waukesha Collect Seven Tons of Medications for Safe Disposal
Milwaukee–Wisconsin Journal Sentinel
April 30, 2014

Nebraskans and Iowans Turn in Thousands of Pounds of Old Medications
May 1, 2014

Harford Co Collects 1389 Pounds of Unused Expired Medicines
Fox45 (Maryland)
April 29, 2014

KSP Collects 1,200 Pounds of Prescription Medication During 'Take Back' Event
KFVS (Kentucky)
April 30, 2014

UNITE Collects Nearly One Ton of Unwanted Prescription Medication
WYMT (Kentucky)
May 1, 2014

Save the Date

Prevention of Youth Substance Abuse in Rural Communities Conference: Bringing Hope to Communities in Despair
Coalition for Healthy Youth
August 6–8, 2014
University of South Carolina Lancaster
Lancaster, South Carolina

This three-day conference emphasizes the unique challenges of conducting youth prevention in rural communities. It will focus on exploring the critical issues facing rural communities today, along with effective strategies to meet these challenges. Topics will include the growing use of social media tools, sustainability, and environmental prevention.

Read more:

Sixth Annual American Medicine Chest Challenge National Day of Awareness and Safe Disposal of Prescription and Over-the-Counter Medicine
American Medicine Chest Challenge
November 8, 2014

Upcoming Conferences and Workshops

Prescription for Prevention: Preventing and Responding to Prescription Drug Abuse on Campus
Temple University, Villanova University, U.S. Attorneys' Office, and the Clery Center
June 11, 2014
Philadelphia, Pennsylvania

Pharmacy Diversion Awareness Conference
U.S. Department of Justice, Drug Enforcement Administration
June 28–29, 2014—Renaissance Phoenix (Ariz.) Downtown
July 12–13, 2014—Sheraton Philadelphia (Pa.) Downtown Hotel
August 2–3, 2014—Denver (Colo.) Marriott Tech Center

CADCA's Mid-Year Training Institute 2014
July 20–24, 2014
Orlando, Florida

Twenty-Seventh Annual National Prevention Network Prevention Research Conference
National Prevention Network
September 15–18, 2014

2014 Harold Rogers Prescription Drug Monitoring Program National Meeting
Brandeis University, Prescription Drug Monitoring Program Training and Technical Assistance Center
September 22–24, 2014
Washington, District of Columbia
The Weekly Update is a service provided by the SAMHSA Preventing Prescription Abuse in the Workplace Technical Assistance Center (PAW) to keep the field abreast of recent news and journal articles to assist in forming policy, research, and programs to reduce prescription drug misuse or abuse. Please note, the materials listed are not reflective of SAMHSA's or PAW's viewpoint or opinion and are not assessed for validity, reliability or quality. The Weekly Update should not be considered an endorsement of the findings. Readers are cautioned not to act on the results of single studies, but rather to seek bodies of evidence. Copyright considerations prevent PAW from providing full text of journal articles listed in the Weekly Update.